These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 21210116)
1. 18F-FDG PET/CT for the diagnosis of sarcoidosis in a patient with bilateral inflammatory involvement of the parotid and lacrimal glands (panda sign) and bilateral hilar and mediastinal lymphadenopathy (lambda sign). Oksüz MO; Werner MK; Aschoff P; Pfannenberg C Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):603. PubMed ID: 21210116 [No Abstract] [Full Text] [Related]
2. Lack of Increased FDG Uptake in the Lacrimal and Salivary Glands in Patients With Sarcoidosis and Potential Underlying Mechanism. Shim H; Joo J; Choi HJ; Hyun H; Gerbaudo VH; Kim CK Clin Nucl Med; 2016 Apr; 41(4):274-7. PubMed ID: 26825201 [TBL] [Abstract][Full Text] [Related]
3. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy. Lu SJ; Lee VK; Loo SW Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040 [TBL] [Abstract][Full Text] [Related]
4. Lacrimal, parotid and mediastinal uptake of gallium 67 in sarcoidosis. Lauver JW; Gooneratne NS Br J Radiol; 1979 Jul; 52(619):582-4. PubMed ID: 465947 [No Abstract] [Full Text] [Related]
5. Chronic sialadenitis with marked lymphadenopathy mimicking lymphoma on FDG PET/CT. Liu Y Clin Nucl Med; 2014 Aug; 39(8):738-9. PubMed ID: 24978334 [TBL] [Abstract][Full Text] [Related]
6. Panda sign--avid and symmetrical radiogallium accumulation in the lacrimal and parotid glands. Sulavik SB; Spencer RP; Castriotta RJ Semin Nucl Med; 1991 Oct; 21(4):339-40. PubMed ID: 1754897 [No Abstract] [Full Text] [Related]
7. Diagnosis of unknown sarcoidosis associated to erythema nodosum with 18F-FDG PET/CT. Rampin L; Musto A; Marzola MC; Tadayyon S; Ferretti A; Chondrogiannis S; Grassetto G; Rubello D Rev Esp Med Nucl Imagen Mol; 2013; 32(3):190-2. PubMed ID: 23522858 [TBL] [Abstract][Full Text] [Related]
8. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. Sulavik SB; Spencer RP; Weed DA; Shapiro HR; Shiue ST; Castriotta RJ J Nucl Med; 1990 Dec; 31(12):1909-14. PubMed ID: 2266386 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis. Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers. Yudistiro R; Arisaka Y; Tokue A; Nakajima T BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426 [TBL] [Abstract][Full Text] [Related]
11. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports. Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663 [TBL] [Abstract][Full Text] [Related]
12. Use of integrated FDG-PET/CT in sarcoidosis. Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181 [TBL] [Abstract][Full Text] [Related]